Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Squamous cell carcinoma antigen as a marker of sinonasal inverted papilloma

P. Matoušek, K. Zeleník, K. Safarčík, L. Cábalová, P. Komínek,

. 2014 ; 271 (3) : 535-8.

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008605

This prospective study aimed to evaluate the usefulness of squamous cell carcinoma antigen (SCCA) as a clinical marker of sinonasal inverted papilloma (IP). The potential benefit of SCCA in the diagnosis of unilateral nasal pathology and as a marker of hidden recurrence was evaluated as well. Blood samples from patients with sinonasal IP were examined to determine serum SCCA levels before surgery, the day after surgery, and every 6 months during follow-up. Preoperative and postoperative levels of SCCA were compared. Twenty consecutive patients with histologically confirmed IP were included in the study, conducted between 2000 and 2011. The mean age of the patients was 54.2 years (range 35-72). The mean serum SCCA level before surgery was 3.885 μg/l (range 0.7-7.6). A decrease of the SCCA level to 0.885 μg/l (range 0.1-1.9) was observed on the 1 day after a radical surgical procedure. A statistically significant difference between the preoperative and postoperative levels was observed (P < 0.001). Elevated levels of SCCA during long-term follow-up were observed in three patients. All of them had a recurrence of IP. We conclude that the serum level of SCCA is a useful clinical marker of the presence of sinonasal IP. The level of SCC antigen was significantly lower in patients after IP was completely removed. According to our results, SCCA level also appears to be useful for long-term follow-up (hidden recurrence diagnosis).

000      
00000naa a2200000 a 4500
001      
bmc15008605
003      
CZ-PrNML
005      
20150324112625.0
007      
ta
008      
150306s2014 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00405-013-2604-z $2 doi
035    __
$a (PubMed)23778724
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Matoušek, Petr $u Department of Otorhinolaryngology, University Hospital Ostrava, 17. Listopadu Street 1790, 708 52, Ostrava-Poruba, Czech Republic.
245    10
$a Squamous cell carcinoma antigen as a marker of sinonasal inverted papilloma / $c P. Matoušek, K. Zeleník, K. Safarčík, L. Cábalová, P. Komínek,
520    9_
$a This prospective study aimed to evaluate the usefulness of squamous cell carcinoma antigen (SCCA) as a clinical marker of sinonasal inverted papilloma (IP). The potential benefit of SCCA in the diagnosis of unilateral nasal pathology and as a marker of hidden recurrence was evaluated as well. Blood samples from patients with sinonasal IP were examined to determine serum SCCA levels before surgery, the day after surgery, and every 6 months during follow-up. Preoperative and postoperative levels of SCCA were compared. Twenty consecutive patients with histologically confirmed IP were included in the study, conducted between 2000 and 2011. The mean age of the patients was 54.2 years (range 35-72). The mean serum SCCA level before surgery was 3.885 μg/l (range 0.7-7.6). A decrease of the SCCA level to 0.885 μg/l (range 0.1-1.9) was observed on the 1 day after a radical surgical procedure. A statistically significant difference between the preoperative and postoperative levels was observed (P < 0.001). Elevated levels of SCCA during long-term follow-up were observed in three patients. All of them had a recurrence of IP. We conclude that the serum level of SCCA is a useful clinical marker of the presence of sinonasal IP. The level of SCC antigen was significantly lower in patients after IP was completely removed. According to our results, SCCA level also appears to be useful for long-term follow-up (hidden recurrence diagnosis).
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a antigeny nádorové $x krev $7 D000951
650    _2
$a kohortové studie $7 D015331
650    _2
$a progrese nemoci $7 D018450
650    _2
$a lidé $7 D006801
650    _2
$a longitudinální studie $7 D008137
650    _2
$a lidé středního věku $7 D008875
650    _2
$a lokální recidiva nádoru $x krev $7 D009364
650    _2
$a nádory nosu $x krev $x chirurgie $7 D009669
650    _2
$a invertovaný papilom $x krev $x chirurgie $7 D018308
650    _2
$a nádory vedlejších dutin nosních $x krev $x chirurgie $7 D010255
650    _2
$a prospektivní studie $7 D011446
650    _2
$a serpiny $x krev $7 D015843
650    _2
$a výsledek terapie $7 D016896
650    _2
$a nádorové biomarkery $x krev $7 D014408
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zeleník, Karol
700    1_
$a Safarčík, Kristián
700    1_
$a Cábalová, Lenka
700    1_
$a Komínek, Pavel
773    0_
$w MED00009617 $t European archives of oto-rhino-laryngology official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery $x 1434-4726 $g Roč. 271, č. 3 (2014), s. 535-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23778724 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150324112913 $b ABA008
999    __
$a ok $b bmc $g 1065878 $s 891405
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 271 $c 3 $d 535-8 $i 1434-4726 $m European archives of oto-rhino-laryngology $n Eur Arch Otorhinolaryngol $x MED00009617
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...